POU2F3 and small cell lung carcinoma: The TFs play a key role in SCLC heterogeneity and modulate disease progression; however, the targeting of these TFs is not successful as these modulators are also involved in physiological processes and no small molecule is available to target ASCL1, NEUROD1, or POU2F3.